| Stage | CMC | % of rev | NUE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.7B | 100.00% | $10.4B | 100.00% | NUE ×3.91 |
| Gross profit | $502M | 18.87% | $2.0B | 19.56% | NUE +0.7pp |
| Operating income | $205M | 7.70% | $1.6B | 15.67% | NUE +8.0pp |
| Pre-tax income | $229M | 8.63% | $1.6B | 15.63% | NUE +7.0pp |
| Net income | $213M | 7.99% | $1.3B | 12.31% | NUE +4.3pp |
| Stage | CMC | NUE | Gap · A − B |
|---|---|---|---|
| Revenue | $2.7B100.00% | $10.4B100.00% | NUE ×3.91 |
| Gross profit | 18.87%$502M | 19.56%$2.0B | NUE +0.7pp |
| Operating income | 7.70%$205M | 15.67%$1.6B | NUE +8.0pp |
| Pre-tax income | 8.63%$229M | 15.63%$1.6B | NUE +7.0pp |
| Net income |
| 7.99%$213M |
| 12.31%$1.3B |
| NUE +4.3pp |
No shared counterparties.